Impact of N-Acetylcysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study
- Paola Faverio1⇑,
- Paola Rebora2,
- Emanuela Rossi2,
- Savino del Giudice1,
- Filippo Montanelli1,
- Laura Garzillo1,
- Sara Busnelli1,
- Fabrizio Luppi1,
- Maria Grazia Valsecchi2 and
- Alberto Pesci1
- 1School of Medicine and Surgery, University of Milano Bicocca; Respiratory Unit, San Gerardo Hospital, ASST Monza, Monza, Italy
- 2Bicocca Bioinformatics Biostatistics and Bioimaging B4 Center, University of Milano Bicocca, Monza, Italy
- Corresponding author: Paola Faverio (paola.faverio{at}unimib.it)
Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Faverio has nothing to disclose.
Conflict of interest: Dr. Rebora has nothing to disclose.
Conflict of interest: Dr. Rossi has nothing to disclose.
Conflict of interest: Dr. Del Giudice has nothing to disclose.
Conflict of interest: Dr. Montanelli has nothing to disclose.
Conflict of interest: Dr. Garzillo has nothing to disclose.
Conflict of interest: Dr. Busnelli has nothing to disclose.
Conflict of interest: Dr. Luppi has nothing to disclose.
Conflict of interest: Dr. Valsecchi has nothing to disclose.
Conflict of interest: Dr. Pesci has nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received September 6, 2021.
- Accepted November 17, 2021.
- Copyright ©The authors 2021
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org